David Epstein

(Mr. David Epstein)

Currently holds a position at Evelo Biosciences Inc

Positions
Position Company Period
Chairman of the Board Evelo Biosciences Inc Sept. 17, 2019 -
Director Evelo Biosciences Inc March 1, 2017 - Sept. 17, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
May 31, 2022 May 27, 2022
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
17,123 +25.6%
1.46
25,000 USD 		17,123 +25.6% 1.46 25,000 USD
April 22, 2022 April 21, 2022
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		B Purchase
30,000 +0.6%
1.44
43,329 USD 		30,000 +0.6% 1.44 43,329 USD
March 18, 2022 March 16, 2022
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
26,178 +19.4%
1.91
50,000 USD 		26,178 +19.4% 1.91 50,000 USD
Feb. 16, 2021 Feb. 11, 2021
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		PS Planned sale
26,704 -0.6%
14.93
398,560 USD 		26,704 -0.6% 14.93 398,560 USD
Feb. 10, 2021 Feb. 10, 2021
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		PS Planned sale
7,404 -0.2%
14.79
109,525 USD 		7,404 -0.2% 14.79 109,525 USD
Feb. 10, 2021 Feb. 9, 2021
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		PS Planned sale
2,100 -0.0%
14.83
31,146 USD 		2,100 -0.0% 14.83 31,146 USD
Feb. 10, 2021 Feb. 8, 2021
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		PS Planned sale
89,233 -1.9%
14.88
1,328,117 USD 		89,233 -1.9% 14.88 1,328,117 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
200 +1.1%
7.02
1,404 USD 		200 +1.1% 7.02 1,404 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
500 +2.9%
6.98
3,490 USD 		500 +2.9% 6.98 3,490 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +6.2%
6.91
6,910 USD 		1,000 +6.2% 6.91 6,910 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
800 +5.3%
7.16
5,728 USD 		800 +5.3% 7.16 5,728 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
4,970 +48.6%
6.49
32,255 USD 		4,970 +48.6% 6.49 32,255 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
30 +0.3%
6.45
194 USD 		30 +0.3% 6.45 194 USD
Dec. 14, 2020 Dec. 11, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
200 +2.0%
6.40
1,280 USD 		200 +2.0% 6.40 1,280 USD
Sept. 1, 2020 Aug. 31, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +11.1%
4.58
4,580 USD 		1,000 +11.1% 4.58 4,580 USD
Sept. 1, 2020 Aug. 31, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +12.5%
4.48
4,480 USD 		1,000 +12.5% 4.48 4,480 USD
Sept. 1, 2020 Aug. 31, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +14.3%
4.47
4,470 USD 		1,000 +14.3% 4.47 4,470 USD
Sept. 1, 2020 Aug. 31, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
2,752 +64.8%
4.46
12,274 USD 		2,752 +64.8% 4.46 12,274 USD
Sept. 1, 2020 Aug. 28, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
3,248 +324.8%
4.40
14,291 USD 		3,248 +324.8% 4.40 14,291 USD
Sept. 1, 2020 Aug. 28, 2020
US Evelo Biosciences Inc (EVLO)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +inf%
4.34
4,340 USD 		1,000 +inf% 4.34 4,340 USD
May 20, 2020 May 18, 2020
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
50,000 +73.4%
4.75
237,500 USD 		50,000 +73.4% 4.75 237,500 USD
March 19, 2020 March 17, 2020
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		B Purchase
5,000 +0.1%
3.76
18,800 USD 		5,000 +0.1% 3.76 18,800 USD
March 17, 2020 March 13, 2020
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		B Purchase
5,000 +0.1%
4.00
20,000 USD 		5,000 +0.1% 4.00 20,000 USD
March 17, 2020 March 13, 2020
US Rubius Therapeutics Inc (RUBY)
Pharmaceuticals & Medical Research 		B Purchase
5,000 +0.1%
3.82
19,100 USD 		5,000 +0.1% 3.82 19,100 USD
March 2, 2020 Feb. 28, 2020
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
2,005 +3.0%
3.75
7,519 USD 		2,005 +3.0% 3.75 7,519 USD
March 2, 2020 Feb. 27, 2020
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
12,800 +24.0%
3.65
46,720 USD 		12,800 +24.0% 3.65 46,720 USD
July 18, 2019 July 17, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +3.3%
7.55
7,550 USD 		1,000 +3.3% 7.55 7,550 USD
July 10, 2019 July 10, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
1,322 +4.6%
8.07
10,669 USD 		1,322 +4.6% 8.07 10,669 USD
July 10, 2019 July 9, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
4,200 +16.9%
8.24
34,608 USD 		4,200 +16.9% 8.24 34,608 USD
July 10, 2019 July 8, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
274 +1.1%
9.00
2,466 USD 		274 +1.1% 9.00 2,466 USD
July 3, 2019 July 3, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
56 +0.3%
8.99
503 USD 		56 +0.3% 8.99 503 USD
July 3, 2019 July 2, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
3,500 +22.6%
8.77
30,678 USD 		3,500 +22.6% 8.77 30,678 USD
July 3, 2019 July 1, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
1,000 +6.9%
8.74
8,735 USD 		1,000 +6.9% 8.74 8,735 USD
July 1, 2019 June 28, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
5,400 +37.0%
10.04
54,216 USD 		5,400 +37.0% 10.04 54,216 USD
July 1, 2019 June 27, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
100 +0.7%
9.15
915 USD 		100 +0.7% 9.15 915 USD
June 27, 2019 June 26, 2019
US Axcella Health Inc (AXLA)
Pharmaceuticals & Medical Research 		B Purchase
14,500 +inf%
9.57
138,765 USD 		14,500 +inf% 9.57 138,765 USD

Modal body text goes here.